The action of antidepressant drugs on 5‐hydroxy‐tryptamine uptake by platelets ‐ relationship to therapeutic effect
- 1 April 1981
- journal article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 63 (s290) , 236-243
- https://doi.org/10.1111/j.1600-0447.1981.tb00725.x
Abstract
The uptake of 5‐hydroxytryptamine (5‐HT) by the blood platelets of depressive patients treated with amitriptyline and zimelidine has been examined. Both drugs significantly reduce the uptake of 5‐HT into the platelet and the degree of inhibition is correlated with the plasma drug level of amitriptyline. No significant correlations could be detected between the degree of inhibition of uptake and clinical change. The accepted mode of action of tricyclic antidepressant drugs, i.e. the inhibition of reuptake of released amines, is discussed.Keywords
This publication has 16 references indexed in Scilit:
- Zimelidine: A therapeutic and pharmacokinetic study in depressionPsychopharmacology, 1979
- Platelet 5-hydroxytryptamine accumulation in depressive illnessClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Brain histamine receptors as targets for antidepressant drugsNature, 1978
- The Human PlateletArchives of General Psychiatry, 1977
- Platelet 5-HT uptake and release stopped rapidly by formaldehydeNature, 1975
- Blood platelets as a model for monoamine-containing neuronesProgress in Neurobiology, 1973
- The inhibition of human platelet 5-hydroxytryptamine uptake by tricyclic antidepressive drugs. The relation between structure and potencyJournal of Pharmacy and Pharmacology, 1969
- Clinical Trial of the Treatment of Depressive IllnessBMJ, 1965
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934